<DOC>
	<DOCNO>NCT00605254</DOCNO>
	<brief_summary>This study test use radioactive substance call [ 11C ] dLop measure P-glycoprotein ( P-gp ) use positron emission tomography ( PET ) imaging . The P-gp protein act pump cell , affect variety function , limit drug absorption elimination decrease drug penetration certain tissue , brain . It major obstacle successful chemotherapy pump cancer drug cell , interfere treatment . Decreased P-gp function may contribute disorder Parkinson disease Alzheimer disease , whereas high level protein find patient epilepsy several form drug-resistant cancer tumor . This study determine uptake clearance [ 11C ] dLop radiation exposure organs body ass possible use study P-gp function . Healthy normal volunteer 18 51 year age may eligible study . Candidates screen medical history , physical examination blood urine test . Participants undergo follow procedure : - Electrocardiogram ( ECG ) : A test electrical function heart . - Brain PET scan : PET image us small amount radioactive chemical call tracer label active area brain activity see special camera . The tracer use study [ 18F ] FMPEP-d ( 2 ) . Before start scan , catheter ( plastic tube ) place vein arm inject tracer another catheter place artery wrist obtain blood sample scan . For procedure , subject lie scanner bed . A special mask fit head attach bed help keep person head still scan image clear . A brief scan do tracer inject provide measure brain helpful calculate information subsequent scan . After tracer inject , picture take 2.5 hour , subject lie still scanner bed . Blood urine test do 24 hour scan . - Magnetic resonance imaging ( MRI ) : An MRI scan do within 1 year ( ) PET scan . This procedure use magnetic field radio wave produce image brain . The subject lie table move scanner ( tube-like device ) , wear earplug muffle noise machine scan process . The test take 1 hour ... .</brief_summary>
	<brief_title>PET Imaging P-glycoprotein Function Using 11CdLop</brief_title>
	<detailed_description>P-glycoprotein ( P-gp ) ATP-binding cassette ( ABC ) transporter major efflux pump blood-brain barrier . P-gp several physiological role limit drug absorption , active drug elimination , limit drug penetration sensitive tissue ( e.g. , brain testis ) ( Fromm , 2004 ) . Reduced activity expression P-gp may contribute neurodegenerative disorder Parkinson Alzheimer disease . The reduced activity P-gp ( i.e. , decrease neuroprotection blood brain barrier ) may allow harmful pesticide access brain damage brain dopaminergic cell group possibly lead Parkinson disease ( Betarbet et al. , 2000 ; Kortekaas et al. , 2005 ) . The increased deposition beta-amyloid Alzheimer disease , may due part , decrease elimination cerebral beta-amyloid brain ( Vogelgesang et al. , 2002 ) . Conversely , overexpression P-gp find epilepsy several form multi drug resistant cancer tumor ( Brandt et al. , 2006 ; Szakacs et al. , 2006 ) . In vivo evaluation P-gp function brain throughout body important disease state , therapeutic diagnostic drug evaluation . P-gp function assess healthy volunteer positron emission tomography ( PET ) use [ 11C ] verapamil , nevertheless , accurate quantification PET radioligand difficult due large contribution radiometabolites low signal ( Ikoma et al. , 2006 ; Lee et al. , 2006 ; Lubberink et al. , 2007 ) . Therefore , recently develop [ 11C ] dLop alternative radioligand image P-gp function , allow accurate quantification P-gp high signal less contribution radiometabolites . In current protocol , wish evaluate [ 11C ] dLop healthy volunteer determine kinetics brain image P-gp function . In order simulate P-gp dysfunction healthy volunteer administer P-gp inhibitor tariquidar . We perform brain PET scan use [ 11C ] dLop P-gp blockade order quantify P-gp function blood-brain barrier .</detailed_description>
	<mesh_term>Krestin</mesh_term>
	<criteria>DESCRIPTION OF STUDY POPULATIONS : For dose escalation study use oral tariquidar , select healthy adult female male volunteer ( age 1851 year old ) . These healthy volunteer medication free , exclude birth control pill . These subject ask abstain medication 16 day 1 week participation study . For AD study , select male female AD patient agematched volunteer least 45 year age . INCLUSION CRITERIA : 1 . Patients diagnosis probable Alzheimer disease . All patient must meet capacity criterion consent research ( see Consent document process ) . 2 . Healthy volunteer . EXCLUSION CRITERIA : 1 . Current psychiatric disease , illicit substance use , severe systemic disease base history physical exam . 2 . Laboratory test clinically significant abnormality . Normal organ marrow function define : total leukocyte count great equal 3000 cells/ul , ANC great equal 1500 cells/ul , platelet count great equal 100,000 cells/ul , serum creatinine less equal 2.0 time upper limit normal , bilirubin less equal 1.5 time upper limit normal , hemoglobin 9.0 g/dL , serum calcium less equal 12.0 mg/dL , AST/ALT le equal 1.5 time upper limit normal , PT le equal 1.5 time upper limit normal . 3 . Prior participation research protocols clinical care last year radiation exposure include protocol would exceed guideline set Radiation Safety Committee ( RSC ) . 4 . Pregnancy breast feed . 5 . Positive HIV test . 6 . Positive result urine screen illicit drug . 7 . You lie back extend period time . 8 . Use bloodthinning medication ( warfarin ; aspirin allow ) , current prior history coagulopathy . This necessary subject arterial catheter placement . 9 . History neurological disease Alzheimer disease . 10 . For oral tariquidar doseescalation study : Subjects take medication birth control pill . 11 . For Alzheimer disease patient agematched volunteer : Subjects take medication know substrate Pgp safely discontinue study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>51 Years</maximum_age>
	<verification_date>September 4, 2014</verification_date>
	<keyword>P-Glycoprotein</keyword>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>Blood Brain Barrier</keyword>
	<keyword>Quantitative Imaging</keyword>
	<keyword>Multi-Drug Transporter</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
</DOC>